We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$11.4B
AUM Growth
+$504M
(+4.6%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
2,458
New
259
Increased
1,134
Reduced
877
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$23.1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$23.1M |
| 3 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$19M |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$15.7M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$28M |
| 2 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$23.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$18.3M |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$9.64M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.41% |
| 2 | Financials | 4.96% |
| 3 | Healthcare | 3.93% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Automatic Data Processing
ADP
$108B
| $6.41M | 0.06% |
39,708
+1,247
| +3% | +$206K |
|
327
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $6.4M | 0.06% |
190,384
+2,067
| +1% | +$68.3K |
|
328
Fidelity MSCI Health Care Index ETF
FHLC
$3.41B
| $6.35M | 0.06% |
146,407
-15,207
| -9% | -$673K |
|
329
iShares Core S&P US Value ETF
IUSV
$27.8B
| $6.34M | 0.06% |
109,754
+18,008
| +20% | +$1.02M |
|
330
First Merchants
FRME
$2.69B
| $6.32M | 0.06% |
167,895
+313
| +0.2% | +$11.7K |
|
331
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.62B
| $6.31M | 0.06% |
59,075
-8,599
| -13% | -$913K |
|
332
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $6.31M | 0.06% |
32,718
+1,807
| +6% | +$358K |
|
333
McKesson
MCK
$105B
| $6.29M | 0.06% |
46,033
+2,206
| +5% | +$313K |
|
334
Cigna
CI
$72.4B
| $6.28M | 0.06% |
+41,382
| New | +$6.73M |
|
335
Moderna
MRNA
$24.2B
| $6.28M | 0.06% |
+394,401
| New | +$5.83M |
|
336
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
| $6.26M | 0.05% |
182,568
+3,880
| +2% | +$135K |
|
337
VanEck Intermediate Muni ETF
ITM
$2.13B
| $6.25M | 0.05% |
+124,171
| New | +$6.26M |
|
338
Kraft Heinz
KHC
$29.2B
| $6.24M | 0.05% |
223,297
+34,403
| +18% | +$990K |
|
339
WisdomTree US SmallCap Earnings Fund
EES
$727M
| $6.21M | 0.05% |
174,363
-5,924
| -3% | -$207K |
|
340
Advanced Micro Devices
AMD
$774B
| $6.19M | 0.05% |
213,632
-13,226
| -6% | -$415K |
|
341
Enbridge
ENB
$113B
| $6.17M | 0.05% |
175,889
+28,873
| +20% | +$999K |
|
342
Hershey
HSY
$36.6B
| $6.14M | 0.05% |
39,648
-2,582
| -6% | -$390K |
|
343
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $6.1M | 0.05% |
143,900
+1,200
| +0.8% | +$52.5K |
|
344
iShares Core S&P US Growth ETF
IUSG
$33.6B
| $6.04M | 0.05% |
96,133
+13,406
| +16% | +$848K |
|
345
Archer Daniels Midland
ADM
$38.8B
| $6.04M | 0.05% |
147,065
+225
| +0.2% | +$8.96K |
|
346
iShares Silver Trust
SLV
$31.5B
| $6.03M | 0.05% |
378,495
+113,380
| +43% | +$1.8M |
|
347
Global Net Lease
GNL
$1.91B
| $5.98M | 0.05% |
306,491
+12,203
| +4% | +$238K |
|
348
Colgate-Palmolive
CL
$73.6B
| $5.97M | 0.05% |
81,263
+1,446
| +2% | +$105K |
|
349
Invesco Dorsey Wright Momentum ETF
PDP
$1.49B
| $5.97M | 0.05% |
98,090
+9,075
| +10% | +$559K |
|
350
Janus Henderson Short Duration Income ETF
VNLA
$3.35B
| $5.97M | 0.05% |
119,405
+2,869
| +2% | +$143K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Cambridge Investment Research Advisors held 2,458 positions worth $11.4B, up 4.6% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors deployed $402M of net new capital in Q3 2019, opening 259 new positions and adding to 1,134 existing holdings. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $28M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
- Cambridge Investment Research Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $23.1M increase.
- Cambridge Investment Research Advisors's biggest Q3 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $28M.
- Cambridge Investment Research Advisors fully exited DXC Technology in Q3 2019, selling an estimated $3.71M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $11.4B portfolio in Q3 2019.
- Cambridge Investment Research Advisors opened 259 new positions and closed 119 in Q3 2019.
- Cambridge Investment Research Advisors's portfolio value rose 4.6% quarter-over-quarter to $11.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.